Skin disease affects 25% of Americans and ranks as the 18th greatest cause of Disability Adjusted Life Years (DALY) globally. This places a heavy burden on individuals’ wellbeing, but with increased knowledge about treatments available, more people are seeking dermatology services worldwide. As a result, the demand for such expertise is expected to grow at an annual rate of 6.9% until 2030 in the dermatology market projection growth chart.
In addition to the need for enhanced accessibility to dermatologists, there is also a rising necessity for innovative and sophisticated therapies that offer better results while causing minimal side effects. The escalation in clinical trials within the field of dermatology can be linked to various other circumstances as well, including:
Advancements in technology have led to greater accessibility for remote monitoring, including telemedicine and the ability to document patient-reported outcomes.
Clinical trials decentralization.
Further research into diseases like psoriasis and atopic dermatitis can now be conducted due to the recent developments in immunology and precision medicine.
Increased recognition of clinical trials via social media.
Research advancements in dermatology resulted in contract research organizations (CROs) catering exclusively to this field. With more sponsors and government agencies seeking external assistance for clinical trial procedures, such CROs provide valuable services within this therapeutic domain.
The dermatology CRO industry is projected to witness a Compound Annual Growth Rate (CAGR) of 8.7% from 2022 until 2032, highlighting its promising growth prospects over the next decade.
What is the Role of CROs in Dermatology Clinical Trials?
The main objective of a CRO is to furnish pharmaceutical, biotech and medical device enterprises with an off-site solution for managing their clinical trials daily. Full-service provision or specialized services may be supplied by different CROs.
There are numerous advantages to partnering with CROs, some of which include:
Clinical trials already have established standard operating procedures.
Making technology readily available and utilizing it for speedy trial proceedings.
Expertise in therapy.
Relationships with clinical sites or investigators that already exist.
Possessing a thorough knowledge and proficiency in regulatory standards.
The ascent of Dermatology Contract Research Organizations
In recent years, the utilization of digital tools and streamlined operations through technology has enabled various CROs specialized in dermatology clinical trials to significantly expand their business.
Included in the list of rapidly expanding dermatology CROs are three notable examples:
Curebase is the leading dermatology CRO
Curebase, established in San Francisco back in 2012, is a full-service CRO providing end-to-end services. These include study protocol development and design, activation and identification of sites for research studies, platform configuration through software training sessions as well as recruitment & retention management – ensuring optimal project coordination.
They use innovative technology such as ePROs (electronic patient-reported outcomes), telemedicine tools that allow remote monitoring of patients’ health status/care needs within their comfort at home setting or alternate care locations like community-based centers.
Besides this they embrace wearables to gather relevant data with ease backed up by EDC (electronic data capture) systems on the ground which allows Clinical Research Managers/physicians/research coordinators easy access healthcare information helping make informed decisions quickly without wasting time shuffling paper records around.
Additionally, Curebase specializes also diagnostic-focused clinical trials bringing an abundance experience quipped with demonstrated success over the years putting them ahead competitors across several fronts while forging quality standards hands down one too many times.
Since last year, Curebase has increased its employee count by 283%, now employing a total of 138 people. With an annual revenue of US$14.1 million per year, the company successfully completed Series B funding in May 2022 and raised US$40 million while also gaining ten new investors such as Gilead Sciences recently included in their investment portfolio.
Eclevar Medtech is also an upright Dermatology CRO
Eclevar Medtech is a global clinical research organization (CRO) based in Paris, France that employs advanced technology to offer comprehensive global clinical trial services.
Eclevar Medtech dermatology CRO aims to revamp traditional research methods through an integrated system with innovative technology with focus on the diagnosis and treatment of diseases of the skin, hair and nails.
The fully encrypted and compliant platform of the Eclevar Medtech CRO adheres to regulatory standards such as HIPAA, GDPR, and 21 CRF Part 11 while efficiently integrating EDC, eSource & ePRO for simplified management of clinical trials.
There are diverse types of CROs available, ranging from full-service organizations with an international reach to specialized niche groups catering towards specific areas within a sector.
Specialized clinical trials services provided by expert-oriented CROs simplify moving new products through approval processes like FDA/ CE or UKCA marketing without necessitating device or IVD sponsors maintain additional in-house staff specifically dedicated behind-the-scenes during these stages as well!
Biorasi is the third CRO specializing in Dermatology
Established in Aventura, Florida in 2002, Biorasi is a global CRO with offices across the Americas, Europe and APAC. The company has over 15 years of experience specializing in dermatology – specifically atopic dermatitis, plaque psoriasis and rare skin conditions. Utilizing digital technology to facilitate decentralized trials and remote patient engagement is central to Biorasi’s focus on maximizing speed-to-market.
The number of employees at Biorasi has grown by 28% in the past year, reaching a total of 658. The estimated annual revenue presently stands at US$132.3 million.
Accelerate your trials by partnering with a reliable CRO
Eclevar Medtech Dermatology CRO employs the best technology to reduce human error and streamline the entire workflow from beginning until end. As a result, they can accomplish efficient onboarding, enrollment procedures, communication protocols, data collection processes and site activation within 30 days.
Faster and higher quality clinical trials are ensured by the team’s proficient experts, project managers and CRAs specialized in dermatology studies, reputable leaders on the scientific advisory board from within industry circles, as well as a robust network of investigators.
Eclevar Medtech provides fixed-price contracts that eliminate change orders, thereby promoting greater efficacy in the trial process. Reach out to us now for additional details on how we can assist with your dermatology clinical study.
Contact us today and discover our potential contribution towards your research efforts.
